Advertisement
Advertisement
Trending on Urology Times
1
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
2
NeoBLAST trial tests active surveillance after complete response in MIBC
3
MIBC Treatment Timeline and Skin Toxicity: What Urologists Should Know
4
What the Efficacy Data from KEYNOTE-B15/EV-304 Revealed
5